Applications published 4 November 2009

Proton-pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
Odidi, Isa 2112920*

A controlled release compsn
Fujifilm Manufacturing Europe 2112921*

Polyamide rate-modulated monolithic drug delivery system
University of the Witwatersrand 2112922*

Intranasal, buccal and sublingual administration of metanicotine analogues
Targacept 2112923*

Delta 9-tetrahydrocannabinol processing
Resolution Chemicals 2112924*

Solid pharmaceutical dosage formulations
Abbott Laboratories 2112925*

Use of estrogen receptor beta selective ligands for treating acute lung injuries
Wyeth 2112926*

Method for treatment of overfiltering and leaking blebs with sterile talc
Mor Research Applications 2112927*

Synthesis of novel xylosides and potential uses thereof
University of Utah Research Foundation 2112928*

Herbal formulation for wound healing
Sunev Pharma Solution 2112929*

Modulation of NKT cell activity with antigen-loaded cdid molecules
Vaccinex 2112930*

• Methods and compsns for transdermal delivery of nucleotides
Transderm 2112931*

• Polymeric materials suitable for ophthalmic devices and methods of manufacture
PowerVision 2112932*

• An apparatus and method for in vivo intracellular transfection of gene, siRNA, shRNA vectors, and other biomedical diagnostic and therapeutic drugs and molecules for the treatment of arthritis and other orthopedic diseases in large animals and humans
The Regents of the University of California 2112942*

• A method for the delivery of a therapeutic substance into the skin
Galderma Research & Development 2112943*

• Fluorocombretastatin and derivatives thereof
Sigma-Tau Industrie Farmaceutiche Riunite 2112990*

• New synthons for the synthesis of chiral peptide nucleic acids and methods for preparing the same
Nanodream 2112991*

• A process for the preparation of 2-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-(S)-alanyl]-(1S, 3S, 5S)-2-azabicyclo [3.3.0] octane-3-caboxylic acid
Instytut Farmaceutyczny 2112992*

• Substituted tetrahydropyrrolo-pyrazine compounds having affinity with the KCNQ2/3 K+ channel and use thereof in medicaments
Gruenenthal 2112993*

• Electroluminescent metal complexes with benzotriazoles
BASF 2112994*

• 23-substituted bile acids as TGR5 modulators and methods of use thereof
Intercept Pharmaceuticals 2112995*

• Use of a first dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen
ALK-Abello 2112996*

• Recombinant XRGD-enriched gelatins having high stability
Fujifilm Manufacturing Europe 2112997*

• RGD containing recombinant gelatin
Fujifilm Manufacturing Europe 2112998*

• Non-natural recombinant gelatins with enhanced functionality
Fujifilm Manufacturing Europe 2112999*

• Novel sialidase
DSM  2113027*

• Polypeptides with starch debranching activity
Novozymes 2113028*

• In vivo genome-wide mutagenesis
University of Utah Research Foundation 2113029*

• Genes involved in mitochondrial biogenesis
Novartis 2113030*

• Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
Bayer Schering Pharma Aktiengesellschaft 2113031*

• Human diabetes susceptibility shank2 gene
Integragen 2113032*

• Substances capable of potentiating laminin 5 productivity in epidermal cells and their use
Shiseido 2113245

• Compsns for delivery of therapeutic agents into the eyes and methods of making and using the same
Allergan 2113246

• High efficiency encapsulation of nucleic acids in lipid vesicles
The University of British Columbia 2113247

• Pharmaceutical compsn comprising N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methy;]-2,4-dimethyl-1H-pyrrole-3-carboxamide
Ratiopharm 2113248

• Antimycotic patch
Nichiban 2113249

• Patch package structure
Nitto Denko 2113250

• Use of compounds as inhibitors for helicobacter flavodoxin
Universidad de Zaragoza 2113251

• A forsythoside injection and preparation thereof
Shanghai Youssen New Medicine Exploitation 2113252

• Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
Immatics Biotechnologies 2113253

• Compsns for treating an inflammatory auto-immune condition
TXCell 2113254

• Cytotoxic immunoglobulin
f-star Biotechnologische Forschungs- und Entwicklungses 2113255

• PEGylated rhGH compounds
Ascendis Pharma 2113256

• Polyeoelctorlyte with positive net charge for use as medicament and diagnostic for cancer
Consorzio per il Centro di Biomedica Moleculare 2113257

• Aurone derivative-containing compsn for diagnosis
Nagasaki University 2113258

• MAPK/ERK kinase inhibitors
Takeda Pharmaceutical 2113500

• 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors
Laboratoires del Dr Esteve 2113501

• Hydrazone type compounds and the use thereof in pharmaceutical compsns for the treatment of cardiovascular disease
Clinigenetics 2113502

• New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
Laboratoires Almirall 2113503

• Preparation of N-6 demethylated, 9,10-dihydrolysergic acid alkyl esters
LEK Pharmaceuticals 2113504

• A crystalline form III of anhydrous moxifoxacin hydrochloride and process for the preparation thereof
Dr Reddy's Laboratories Ltd; Dr Reddy's Laboratories Inc 2113505

• Salts of clopidogrel and process for preparation
Cadila Healthcare 2113506

• Novel triazole nucleoside derivatives, their preparation and their application in therapeutics
INSERM (Institut National de la Sante at de la Recherche Medicale): Centre National de la Recherche Scientifique (CNRS) 2113508

• Modulation of the expression of STAT-1 dependent genes
Avontec 2113509

• Pepstatin A derivatives
Freie Universitaet Berlin 2113510

• Metastin derivatives and use thereof
Takeda Pharmaceutical 2113513

• Method for creating hypoallergenic glycoproteins in mutated or genetically modified plants or plant cells for creating hypoallergenic glycoproteins
Westfaelische Wilhelms-Universitaet Muenster 2113514

• GaINAc specific binding molecules and uses thereof
Vereniging voor Christelijk Wetenscheppelijk Onderwijs 2113515

• Antibodies against C5 inhibiting type II endothelial cell activation
Genentech 2113516

• Complexes comprising angiostatin and its fragments, preparation, preparing methods and uses thereof
Protgen 2113517

• Bone/cartilage formation-stimulating agent
PG Research Group 2113518